- Home
- Psychiatry
Psychiatry
Continuing Medical Education: Psychiatry: Genetics CME: UC San Diego: 2008 Health and Wellness Forum Developmental Disabilities: Innovation in Diagnosis, Treatment & Service Delivery: San Diego, CA: Conference CME: September 24-26, 2008
- By University of California, San Diego - School of Medicine
- Published 07/30/2008
- Quality Assurance , Psychiatry , Genetics
- Unrated
2008 Health and Wellness Forum Developmental Disabilities: Innovation in Diagnosis, Treatment & Service Delivery
University of California, San Diego--School of Medicine
September 24-26, 2008
This year's developmental disabilities conference will include five sets of workshops focusing on autism, genetics, early intervention, risk management, and special populations, as well as keynote presentations and a poster session / reception. Twenty-five different workshops will be offered, concentrating on topics such as assistive technology, effective and ineffective treatments, expanded screening in genetics, co-occurring medical conditions common to certain syndromes, and nutrition. The interactive reception and poster session provides attendees with the opportunity to speak directly with project partners.
University of California, San Diego--School of Medicine
September 24-26, 2008
This year's developmental disabilities conference will include five sets of workshops focusing on autism, genetics, early intervention, risk management, and special populations, as well as keynote presentations and a poster session / reception. Twenty-five different workshops will be offered, concentrating on topics such as assistive technology, effective and ineffective treatments, expanded screening in genetics, co-occurring medical conditions common to certain syndromes, and nutrition. The interactive reception and poster session provides attendees with the opportunity to speak directly with project partners.
Continuing Medical Education: Bipolar Disorder CME: ABcomm, Inc.: Understanding the Metabolic Syndrome and the Relationship of Endocrine Issues in Bipolar Disorder, Epilepsy and Other Disease States: San Francisco, CA : Course CME: September 16th
- By ABcomm, Inc.
- Published 07/23/2008
- Primary Care , Psychiatry , Pediatrics , Neurology , Internal Medicine , Headache/Migraine , General Medicine , Family Medicine
- Unrated
Understanding the Metabolic Syndrome and the Relationship of Endocrine Issues in Bipolar Disorder, Epilepsy and Other Disease States
ABcomm, Inc.
September 16th, 2008
This dinner education session is designed to provide physicians with evidence-based information on current issues surrounding the metabolic syndrome and the relationship of endocrine issues in bipolar disorder, epilepsy and other disease states. Additionally, the session will discuss relationships between seizure disorders, psychiatric disturbances and polycystic ovarian syndrome and management strategies.
Continuing Medical Education: Bipolar Disorder CME: ABcomm, Inc.: Recent Developments in the Treatment of Bipolar Disorder: Portland, OR: Course CME: September 23rd, 2008
- By ABcomm, Inc.
- Published 07/22/2008
- Primary Care , Psychiatry , Pediatrics , General Medicine , Family Medicine
- Unrated
Recent Developments in the Treatment of Bipolar Disorder
September 23rd, 2008
This dinner education session is designed to provide physicians with evidence-based information on current issues in the treatment of bipolar disorder. Additionally, it will discuss the recent developments in the diagnosis and management of mixed and manic bipolar patients, considering clinical trials data and consensus treatment guidelines.
Continuing Medical Education: Psychiatry CME: CME Outfitters: Bipolar Depression: Individualizing Treatment to Prevent Relapse and Recurrence: Online Psychiatry CME: September 10, 2008
- By CME Outfitters
- Published 07/15/2008
- Psychiatry
- Unrated
Bipolar Depression: Individualizing Treatment to Prevent Relapse and Recurrence
CME Outfitters
September 10, 2008
There is an unmet need for acute - and in particular, maintenance - pharmacologic treatments that target bipolar depression. Despite the preponderance of depressive symptoms and episodes (versus manic) over the course of both bipolar I and II disorder, and the more frequent functional impairment associated with bipolar depression, there has been a disproportionate lack of attention paid to establishing effective treatment and management of bipolar depression. This has recently begun to change, however, with the approval and addition of atypical antipsychotics to the arsenal of medications used for bipolar depression.
Recently completed studies and trials in progress are expected to contribute to the growing literature supporting the effectiveness of these types of medications for the treatment of bipolar depression. Clinicians are in urgent need of education and performance improvement in the recognition, diagnosis, and acute and maintenance treatment of bipolar depression. Published treatment guidelines are an adequate framework for developing treatment plans. However, clinicians need additional education on pharmacologic treatments for bipolar depression. In this evidence-based, neuroscienceCME TV activity, experts will provide information on pharmacologic treatments for bipolar depression that will enable participants to integrate these findings into current treatment guidelines to further enhance and maintain good patient outcomes.
CME Outfitters
September 10, 2008
There is an unmet need for acute - and in particular, maintenance - pharmacologic treatments that target bipolar depression. Despite the preponderance of depressive symptoms and episodes (versus manic) over the course of both bipolar I and II disorder, and the more frequent functional impairment associated with bipolar depression, there has been a disproportionate lack of attention paid to establishing effective treatment and management of bipolar depression. This has recently begun to change, however, with the approval and addition of atypical antipsychotics to the arsenal of medications used for bipolar depression.
Recently completed studies and trials in progress are expected to contribute to the growing literature supporting the effectiveness of these types of medications for the treatment of bipolar depression. Clinicians are in urgent need of education and performance improvement in the recognition, diagnosis, and acute and maintenance treatment of bipolar depression. Published treatment guidelines are an adequate framework for developing treatment plans. However, clinicians need additional education on pharmacologic treatments for bipolar depression. In this evidence-based, neuroscienceCME TV activity, experts will provide information on pharmacologic treatments for bipolar depression that will enable participants to integrate these findings into current treatment guidelines to further enhance and maintain good patient outcomes.
The Latest News Feeds in Psychiatry
The fourth international stigma conference (2009-01-21) (Jan 21, 2009 04:00) <h3 class="style36::The Fourth International Stigma Conference<br /><em>Together Agai..
Cognitive remediation training for anorexia nervosa (2008-12-16) (Dec 16, 2008 04:00)
The aim of this workshop is to relate theoretical knowledge of cognitive remediation therapy (CRT) f..
Translating advances in biological psychiatry into therapeutics: moving from bench to bedside (2008-11-24) (Nov 24, 2008 04:00)
For further details and to apply, please visit [link=/translating::www.iop.kcl.ac.uk/translating] (S..
The second mediterranean maudsley forum (2008-09-22) (Sep 22, 2008 03:00)
Once again Professor Robin Murray and The <?xml:namespace prefix = st1 /?><st1:placetype w:..
Advanced paternal age linked to increased risk for bipolar disorder (Sep 4, 2008 21:05)
In a large, population-based Swedish study, having an older father was linked with increased risk of..
Strong evidence rules out link between mmr vaccine and autism (Sep 4, 2008 14:44)
Researchers released the latest evidence Wednesday showing no association between vaccination with t..
Cerebellar dysfunction may point to increased bipolar disorder risk (Sep 4, 2008 11:59)
Midline cerebellar dysfunction may be a biomarker for the development of bipolar disorder, say US sc..
Volume 61, supplement 46, 2007 (Sep 4, 2008 06:22)
Nordic Journal of Psychiatry, Volume 61, Supplement 46, 2007. (Source: Nordic Journal of Psychiatry)
Volume 60, number 4, august 2006 (Sep 4, 2008 06:22)
Nordic Journal of Psychiatry, Volume 60, Number 4, August 2006. Loaded on 2008-01-10 (Source: Nordic..
Volume 62, number 3, 2008 (Sep 4, 2008 06:22)
Nordic Journal of Psychiatry, Volume 62, Number 3, 2008. Loaded on 2008-08-31 (Source: Nordic Journa..
